Dr. Dingfield is an Assistant Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania, Director of Palliative Care Education for the University of Pennsylvania Health System and Program Director of the Hospice and Palliative Medicine Fellowship at the University of Pennsylvania in Philadelphia. She is ABIM Board Certified in Internal Medicine and Hospice and Palliative Medicine. Her academic focus is on medical education, including curricular innovation and assessment in competency-based education programs. She is the Chair of the Hospice and Palliative Medicine Advisory Committee.

Dr. Dingfield serves on the American Academy of Hospice and Palliative Medicine (AAHPM) Fellowship Training Committee and the AAHPM Assessment Task Force. She has previously served on Test Materials Development Committees for the National Board of Medical Examiners.

Dr. Dingfield graduated from the University of Michigan Medical School in Ann Arbor. She completed her internal medicine-pediatrics residency at the Hospital of the University of Pennsylvania-Children’s Hospital of Philadelphia, and her hospice and palliative medicine fellowship at the University of Pennsylvania Health System. She holds a master’s degree in education from the University of Pennsylvania Graduate School of Education.

As of April 2026, Dr. Dingfield reported the following external relationships:

Dr. Dingfield serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:  

• The American Academy of Hospice and Palliative Medicine, Chair, Curriculum and Faculty Development Committee, receiving reimbursement for travel expenses.  

Dr. Russo, ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey. Dr. Russo previously served on the ABIM Cardiovascular Test-Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission. She is the Chair of the ABIM Cardiovascular Board.

She is past president of the Heart Rhythm Society (HRS), current member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardio-Obstetrics Council. She previously served on or chaired multiple ACC, AHA and HRS committees, subcommittees and working groups. In addition, she has served as co-chair or member on several guideline and consensus documents, as well as Appropriate Use criteria writing groups. She also serves on editorial boards for several peer-reviewed journals and is a current Associate Editor for Circulation: Arrhythmia and Electrophysiology. She has served on steering committees, events committees and data safety monitoring committees for several clinical trials. Her areas of research interest include implantable cardioverter defibrillators, atrial fibrillation therapies, sex differences in arrhythmias and the role of digital health in arrhythmia management.

Dr. Russo earned a Bachelor of Science in Microbiology at the University of Rochester and a medical degree at the SUNY Downstate Health Sciences University. She completed an internal medicine residency at Drexel University College of Medicine (then the Medical College of Pennsylvania) in Philadelphia and fellowships in cardiovascular disease and electrophysiology at the University of Medicine and Dentistry of New Jersey. 

As of February 2026, Dr. Russo reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:  

• Abbott Laboratories 
• Novartis AG 
• Orchestra BioMed  

Service on data and safety monitoring boards for the following companies, with honoraria:  

• Biosense Webster Inc. 

Service on a research-related steering committee or advisory board for the following companies, without compensation:  

• Medtronic  
• PaceMate  

Work as an author or editor for the following companies, with compensation as listed:  

• UpToDate, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy. 

Dr. Bird is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. She is the Internal Medicine Residency Program Director at Sovah Health – Danville in Danville, Virginia. She has served as the Medical Director of the Critical Care Unit and the Sleep Lab at Sovah Health – Danville since 2005. She is the Chair of the Critical Care Medicine Board. 

In 2016 and 2019, Dr. Bird received the Michael Moore Excellence in Education Award for the education of medical residents. In addition, Dr. Bird speaks to medical students, medical residents and physicians at conferences and lectures for educational purposes and professional development. 

Dr. Bird completed her undergraduate work at Wake Forest University where she graduated with honors. She completed her medical degree, her residency in internal medicine and her fellowship in pulmonary and critical care medicine at the University of North Carolina at Chapel Hill.   

As of May 2026, Dr. Bird reported no ongoing external relationships. 

Dr. Bonura is an Associate Professor of Medicine and Program Director of the Infectious Disease Fellowship at Oregon Health & Science University (OHSU), as well as Director of the Microbiology and Immunology Thread for Undergraduate Medical Education. She serves as Chair of the Education Committee and Vice-Chair of the Infectious Diseases Society of America’s Medical Education Community of Practice. She is the Chair of the ABIM Infectious Disease Board.

She is also one of the founding members of the Educators' Collaborative which brings together faculty from all schools at OHSU (Medicine, Dentistry, Pharmacy, Nursing and Public Health) dedicated to education and furthering this mission at OHSU. In 2019 she became a co-director for the Education Scholars Program, a year-long course dedicated to training the next generation of scholars in health sciences education.

Dr. Bonura received her medical degree from Georgetown University in 2006. Following medical school, she completed her internship and residency at the Hospital of the University of Pennsylvania and New York University where she was also named chief resident. She completed a second fellowship at OHSU in internal medicine and completed her master's degree in clinical research with a focus on medical education methods and outcomes in the undergraduate and graduate settings. Subsequently, Dr. Bonura completed fellowship training at OHSU. She is ABIM Board Certified in Internal Medicine and Infectious Disease.

As of April 2026, Dr. Bonura reported the following external relationships:

Dr. Bonura serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:  

• The Infectious Diseases Society of America, Secretary, Board of Directors, receiving reimbursement for travel expenses.  
• The National Board of Medical Examiners, member, Interdisciplinary Review Committee, receiving reimbursement for travel expenses and honoraria.  

Dr. Carlson is a private rheumatologist at New Haven Rheumatology in New Haven, Connecticut. She is ABIM Board Certified in Rheumatology and Chair of the ABIM Rheumatology Board. She is an Assistant Clinical Professor at Yale University School of Medicine and works with rheumatology fellows a few weeks per year attending the rheumatology service. She also works with Yale medical students in her outpatient office during their primary care and psychiatry clerkship providing rheumatology teaching. Dr. Carlson is also an Assistant Clinical Professor at Frank H. Netter School of Medicine at Quinnipiac University. She is the co-coordinator for the musculoskeletal block for the second-year medical students, designing the curriculum for the musculoskeletal block and delivering lectures on rheumatology to the students.  

Dr. Carlson enjoys volunteering at the New Haven Health Project working with medical students, nursing students, physician assistant students and master’s students providing health screenings to clients at the local food bank. 

Dr. Carlson received her bachelor's degree in biology from Yale University and earned her medical degree from the University of Connecticut School of Medicine in Farmington, Connecticut. She completed her internal medicine residency training, chief residency and rheumatology fellowship at the University of Connecticut. 

As of April 2026, Dr. Carlson reported no ongoing external relationships.

Dr. DeVault is a Professor and Chair of the Department of Medicine, and a member of the Executive Operating Team at the Mayo Clinic Florida. He is ABIM Board Certified in Internal Medicine and Gastroenterology. He is the Chair of the ABIM Gastroenterology Board.

Prior to becoming Chair of Medicine, Dr. DeVault was Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic Florida. Dr. DeVault is a fellow and past president of the American College of Gastroenterology. He is also a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy, and a fellow of the American College of Physicians.

Dr. DeVault conducts research on disorders affecting all aspects of the esophagus and has written more than 250 book chapters, abstracts, editorials and original articles on subjects ranging from the treatment of GERD, dysphagia, esophagitis and Barrett's esophagus to laparoscopic anti-reflux surgery and managed care issues in the treatment of GERD. He also has an interest in gastrointestinal health developing nations, improving professionalism in both trainees and practicing physicians and in the development of a diverse and effective healthcare work force.

He received his undergraduate degree from the University of Tennessee and his medical degree from the Bowman Gray School of Medicine at Wake Forest University. He completed his internship and residency in internal medicine at Vanderbilt University and completed a combined clinical and research fellowship at Jefferson Medical College.

As of May 2026, Dr. DeVault reported no ongoing external relationships.

Ms. Gbedemah is an Infection Prevention Program Manager for Texas Health Harris Methodist Hurst-Euless-Bedford (HEB). Her current role at Texas Health HEB includes overseeing the Infection Prevention Program in the acute care hospital setting, as well as a standalone inpatient behavioral hospital, and an additional five satellite behavioral health campuses. She also serves as an infection prevention consultant for the Agency for Healthcare Research and Quality ECHO National Nursing Home COVID-19 Action Network. Prior to her current position in infection prevention and control she worked as a critical care nurse in various nursing specialties. She is board certified by the Certification Board of Infection Control and Epidemiology. 

She serves on the Board for the Association for Professionals in Infection Control and Epidemiology – Dallas-Fort-Worth Chapter. Prior to her current role as Board Member, she was Conference Chair for two consecutive years. 

Ms. Gbedemah’s interest in infectious disease and epidemiology is ongoing in her current practice. She was recently awarded Frontline Worker of the Year from the Colleyville Chamber of Commerce for all the efforts she put forth during the COVID-19 pandemic for the hospital and the community. She has acquired international experience after completion of a preceptorship in Ghana at Korle-Bu Teaching Hospital, the largest teaching hospital in the country. 

Ms. Gbedemah received her Bachelor of Arts in Biology at the University of North Texas in Denton, Texas. She earned her Bachelor of Science in Nursing at Midwestern State University and a Master of Science in Nursing Informatics at Walden University. 

As of August 2025, Ms. Gbedemah reported no ongoing external relationships.  

Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, Minnesota. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. Previously, Dr. Gertz served as Treasurer for the International Myeloma Society and President of Mayo Staff Officers and Councilors. He also formerly chaired the Mayo Personnel Committee. He is the Chair of the ABIM Hematology Board.

Dr. Gertz has been recognized as a Mayo Distinguished Clinician and in 2014 received the Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström's Macroglobulinemia. He is recognized for contributions in amyloidosis and Waldenström's macroglobulinemia. He has authored more than 500 peer-reviewed publications in the field and is a frequently invited speaker across the country.

Dr. Gertz is a Master of the American College of Physicians. His undergraduate degree was awarded with highest distinction from Northwestern University, where he graduated Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola University Chicago’s Stritch School of Medicine in Maywood, Illinois, where he was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago where he was twice voted Resident of the Year.

As of September 2025, Dr. Gertz reported the following external relationships:

Research-related consulting for the following companies, receiving reimbursement for travel expenses and honoraria:   

• AbbVie Inc., receiving honoraria.  
• Akcea Therapeutics Inc., receiving honoraria.  
• Alexion Pharmaceuticals Inc., receiving honoraria.  
• AstraZeneca plc, receiving honoraria.  
• Alnylam Pharmaceuticals Inc., receiving honoraria.  
• DAVA Oncology, receiving honoraria.  
• Janssen Pharmaceuticals, receiving honoraria.  
• Johnson & Johnson, receiving honoraria.  
• Medscape Education, receiving honoraria.  
• Sanofi, receiving honoraria.  

Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:    

• AbbVie Inc., receiving honoraria.  

Dr. Scharles Alicia Konadu, M.D., serves on the ABIM Gastroenterology sub specialty board and the ABIM Council.

She is a Gastroenterology consultant with Texas Digestive Disease Consultants-GI Alliance in Fort Worth, TX, and is known for her compassionate, patient-centered care and expertise in endoscopy. From 2020 to 2026, she was repeatedly recognized as a Top Doctor by Fort Worth Magazine and honored as a Texas Rising Star by Super Doctors from 2021 to 2025.

Dr. Konadu earned her medical degree at UT Southwestern, followed by residency and fellowship training at Duke University. Beyond her clinical practice, she contributes her expertise to the African Institute for Liver and Digestive Diseases Foundation, where she leads efforts to prevent and treat liver and digestive diseases across African communities through research, education, and professional training. Her global health credentials are further strengthened by hands-on experiences in Ghana and China, where she has engaged in education, clinical exchange, and capacity building to improve digestive health outcomes. She combines technical excellence with a deep commitment to equity, prevention, and community empowerment.

As of May 2026, Dr. Konadu reported the following ongoing external relationships:  

Dr. Konadu serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:  

• African Institute for Liver and Digestive Diseases, Secretary and Board Member, without compensation.  

Mr. Milan is a recognized national and global expert and advocate on HIV. He has been living with HIV for over four decades. He is CEO Emeritus of AIDS United, having served nine years until July 2025 as its President and CEO, leading that national organization’s work on HIV policy, grantmaking and capacity building. He previously served two terms on the ABIM Infectious Disease Board.

Mr. Milan is a lawyer whose career includes leading HIV programs and organizations at the national, regional and global levels. He has addressed millions across the U.S. and Africa in keynotes, presentations and sermons. He serves currently on the Presidential Advisory Council on HIV/AIDS (PACHA), on the HIV Leadership Advisory Council for the U.S. Business Action to End HIV, on the board of AVAC (AIDS Vaccine Advocacy Coalition) and on the Practice Advisory Committee for the UNC Gillings School of Global Public Health. He served for 11 years until 2024 on the Scientific Advisory Board for the President’s Emergency Plans for AIDS Relief (PEPFAR).

He is the immediate past board chair of Funders Concerned About AIDS (FCAA) and board chair emeritus of the Black AIDS Institute. Mr. Milan was vice president for 15 years at two federal public health contractor firms and served at the appointment of the Secretary of Health and Human Services for five years as co-chair of the CDC/HRSA Advisory Committee on HIV and STD (CHAC). Mr. Milan is former AIDS Director for Philadelphia and a former Philadelphia Deputy City Solicitor, and he served six years as Chief of Staff to the president of Temple University.

In addition, he is past president of the National Episcopal AIDS Coalition and the Philadelphia AIDS Consortium. His many honors for his work in HIV have come from the American Bar Association, HRSA, POZ Magazine and the Association of Nurses in AIDS Care. In 2023, he received the Distinguished Alumni Award from the Association of Black Princeton Alumni, and in 2020 an honorary Doctorate of Humane Letters from the Virginia Theological Seminary.

Mr. Milan is a graduate of Princeton University and the New York University School of Law.

As of September 2025, Mr. Milan reported the following external relationships:  

Mr. Milan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:  

• AIDS United, Chief Executive Officer Emeritus, receiving retirement compensation.  
• AIDS Vaccine Advocacy Coalition, member, Board of Directors, without compensation.  
• Funders Concerned About AIDS, Chair, Board, without compensation  
• Rabin Martin, subject content expert.  
• U.S. Business Action to End the HIV Epidemic, member, HIV Leadership Advisory Council, with honoraria.  

Mr. Milan also serves on the scientific advisory board for the President’s Emergency Plan for AIDS Relief and the Presidential Advisory Council on HIV/AIDS.  

Dr. Murin is the Interim Dean of the University of California (UC) Davis School of Medicine. She formerly served as Vice-Chair of Internal Medicine, Associate Dean for Clinical Affairs and Director of the UC Davis Medical Group at UC Davis Health System. Former roles at UC Davis include Program Director for the Pulmonary and Critical Care Fellowship, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine, and Chief of the Medical Staff. Her past national service has included membership on the Accreditation Council for Graduate Medical Education’s Internal Medicine Residency Review Committee and Chair of the Association of Pulmonary and Critical Care Medicine Program Directors. Dr. Murin is ABIM Board Certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine and is the Chair of the Pulmonary Disease Board. 

Dr. Murin's research has been focused in two areas: epidemiology of venous thromboembolism and the effects of smoking on the natural history of breast cancer. She remains active in clinical care and teaching at UC Davis, and recently retired from the VA after nearly 30 years of part-time service as a clinician and educator.  

Dr. Murin received her undergraduate degree from Rutgers University and her medical degree at New York University. She completed her residency in internal medicine at NYC Health + Hospitals/Bellevue and fellowship in pulmonary and critical care medicine at Yale University. She subsequently received a Master of Science in Clinical Epidemiology from the Harvard School of Public Health and a Master of Business Administration from the UC Davis Graduate School of Management. 

As of May 2026, Dr. Murin reported the following external relationships:  

Work as an author or editor for the following companies, with compensation as listed:  

• EBSCO, receiving compensation as an editor.  

Dr. Nair is the Physician-in-Chief of the Lehigh Valley Cancer Institute (LVCI) in Allentown, Pennsylvania, and leads the health network’s academic programs. Dr. Nair is the Medical Director of the LVCI membership in the Memorial Sloan Kettering Cancer Center Alliance and has practiced oncology in the community setting for 27 years. He is the initial holder of the Auxiliary of Lehigh Valley Hospital Endowed Chair in Cancer. He is the Chair of the ABIM Medical Oncology Board and Council Director to the ABIM Board of Directors. He is ABIM Board Certified in Internal Medicine and Medical Oncology.

With clinical expertise in melanoma, kidney cancer and immunotherapy, Dr. Nair’s focus is to provide the highest-quality cancer care, including standard and research treatments. He leads a variety of clinical trials at Lehigh Valley Health Network (LVHN) to provide leading-edge options to patients. He leads the high-dose interleukin-2 program at LVHN for advanced melanoma and kidney cancer. Dr. Nair started the hematology/oncology fellowship at LVHN and served as the initial Program Director.

Dr. Nair has been a site principal investigator in the National Cancer Institute (NCI) Cooperative Group Program for over 25 years and was the first Chair of the NCI Early Phase Central Institutional Review Board. He has been a site principal investigator of over 40 T-cell checkpoint inhibitor trials at LVCI.

Dr. Nair received his medical degree from Jefferson Medical College in Philadelphia. He completed his residency at Geisinger Medical Center in Danville, Pennsylvania, and his fellowship at the University of Pittsburgh.

As of November 2025, Dr. Nair reported the following external relationships:

Funding for clinical trial support, including research staff and expenses, paid to Lehigh Valley Health Network, from the following companies:  

• AVEO Pharmaceuticals Inc., for a research grant studying tivozanib in metastatic renal cancer.  
• Bristol-Myers Squibb, serving as local hospital principal investigator of multicenter immunotherapy clinical trial.  
• Elicio Therapeutics, serving as local principal investigator of multicenter vaccine study in pancreatic cancer, subsite of Memorial Sloan Kettering.  
• Strata Oncology, serving as local hospital principal investigator for genomic testing and clinical trials.  

Dr. O'Neil is a partner at Wilmington Health, a multispecialty group in Wilmington, North Carolina. He served in a variety of roles while on active duty including chief medical resident; Chair, Critical Care Medicine; Pulmonary Division Chief; Pulmonary and Critical Care Fellowship Program Director; Navy specialty leader for Pulmonary/Critical Care Medicine and Graduate Medical Education Director for the National Naval Medical Center.

Dr. O’Neil previously served on the ABIM Pulmonary Disease Board. He is active in clinical practice guideline development with the American College of Chest Physicians and in respiratory care education through the Commission on Accreditation for Respiratory Care (CoARC).

Dr. O’Neil holds an undergraduate degree in chemical engineering from the University of Delaware, a medical degree from Jefferson Medical College in Philadelphia and a master's in healthcare administration from the University of North Carolina at Chapel Hill. He completed his residency and fellowship training at the Naval Hospital in Portsmouth, Virginia. He is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.

As of April 2026, Dr. O'Neil reported the following external relationships:   

Dr. O’Neil serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:  

• The American College of Chest Physicians, Chair, Respiratory Care Interest Group, receiving reimbursement for travel expenses.  
• The Committee on Accreditation for Respiratory Care, member, Board of Commissioners; member, Executive Committee; past president, Board of Commissioners, without compensation.  

American Board of Allergy and Immunology

Dr. Park is an Associate Professor of Medicine in the Division of Allergic Diseases at Mayo Clinic Rochester. He currently serves as the Director for the Mayo Clinic Allergy Fellowship Training Program and was the past chair of Mayo Clinic Health System Allergy. He serves as the chair of the Anaphylaxis, Dermatology and Drug Allergy (ADDA) interest section at the American Academy of Allergy, Asthma & Immunology, and is on the Board of Directors of the American Board of Allergy and Immunology (ABAI).

Dr. Park completed his internal medicine residency at Mayo Clinic Rochester and an internal medicine chief resident year at Mayo Clinic Florida.

View my board certification status via ABMS Website

As of April 2026, Dr. Park reported the following external relationships:   

• Dr. Park reported serving as co-course director for the Mayo Clinic CME program, Clinical Updates in Allergy and Immunology, without compensation.  
• He also serves on the Board of Directors of the American Board of Allergy and Immunology, without compensation.  

Dr. Sehgal is a nationally recognized Geriatric Medicine clinician-educator, developer of innovative educational programming and leader of interprofessional teams. She currently serves as the Cleveland Clinic’s Vice Chief of Education for the Florida Market after being the Program Director for the Geriatric Medicine Fellowship at Cleveland Clinic Florida for the past five years. She is a Clinical Affiliate Professor at Florida Atlantic University (FAU) Schmidt College of Medicine and is board certified by the American Board of Family Medicine in Family Medicine and Geriatric Medicine. She is the Chair of the ABIM Geriatric Medicine Board.

In addition to her leadership roles, Dr. Sehgal is Associate Editor for the Education and Training Section of the Journal of the American Geriatrics Society and past Chair of the American Geriatrics Society (AGS) Teachers’ Section. She previously served as Teaching and Learning Lead for Aquifer Geriatrics, the AGS national online curriculum, where she supported the development of innovative Geriatric Medicine education across the country.

Over the course of her career, Dr. Sehgal has been a principal and co-investigator on multiple grant-funded projects totaling more than $5 million. In 2010, she was awarded a prestigious Geriatric Academic Career Award from the U.S. Bureau of Health Professions. Dr. Sehgal is a champion of providing person-centered care ensuring the best quality of life for her older adult patients while maintaining their safety and independence. Dr. Sehgal attended college and medical school at the University of South Alabama. She completed her residency at Tallahassee Memorial's Family Medicine Residency Program, her geriatric medicine fellowship at the University of Cincinnati and faculty development fellowship at the University of North Carolina at Chapel Hill.

As of April 2026, Dr. Sehgal reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:  

• Wiley-Blackwell, receiving compensation as Section Editor of the Journal of the American Geriatrics Society.  

Dr. Stansbury is an Associate Professor of Medicine and Director of the West Virginia University (WVU) Sleep Evaluation Center in Morgantown, West Virginia. He is also the Sleep Medicine Fellowship Program Director at WVU. He is ABIM Board Certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He is the Chair of the Sleep Medicine Advisory Committee.

He is an active member of the American Thoracic Society and the American Academy of Sleep Medicine and has served in multiple leadership roles including as committee chair for these societies. He is President of the West Virginia Sleep Society and an active member of the West Virginia Rural Health Association.

His research has involved team science and collaboration across multiple institutions. His interest and investigations broadly focus on three main areas: rural health inequity, novel approaches to the diagnosis and management of sleep apnea, and the physiology of occupational lung disease. Dr. Stansbury has published multiple research and review articles in these domains and multiple book chapters focused on sleep medicine and occupational lung disease.

Dr. Stansbury earned his medical degree at WVU School of Medicine and completed his internal medicine residency at the University of Kentucky College of Medicine in Lexington, Kentucky. He completed his pulmonary and critical care fellowship at WVU and his sleep medicine fellowship at the University of Pittsburgh School of Medicine in Pennsylvania.

As of May 2025, Dr. Stansbury reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to West Virginia University, from the following nonprofit healthcare-related organizations:

• The American Thoracic Society, receiving grant funding for American Thoracic Society Vaccine Initiative.
• The National Institutes of Health/National Heart, Lung & Blood Institute, receiving grant funding supporting work to improve sleep apnea care disparity in rural communities. 

Dr. Twining is an ABIM Board Certified endocrinologist and Medical Director at the Maine Medical Partners Center for Endocrinology and Diabetes, a group of eight endocrinologists in Scarborough, Maine. She practices general endocrinology with a focus on thyroid disease, metabolic bone disease and transitional care. Additionally, Dr. Twining is an Assistant Professor of Medicine at Tufts School of Medicine and teaches Tufts medical students and residents at Maine Medical Center, where she also serves as an advisor to internal medicine-pediatrics residents. She is the Chair of the ABIM Endocrinology, Diabetes and Metabolism Board.

She has been a member of the American Association of Clinical Endocrinologists (AACE) board of directors since 2015. She served previously as AACE's representative to the Young Physicians Section of the American Medical Association and as the Fellow-in-Training Representative to the Board of Directors. She also served on the board of the New England Chapter of AACE and was its president in 2013-2014. She has served on many AACE committees, including Endocrine Training Support, Socioeconomics, Chapters, Membership, Pediatric Endocrinology, and Endocrine University and the Task Force on Women in Endocrinology, among others.

Dr. Twining has an Artium Baccalaureus from Harvard College and a medical degree from Duke University School of Medicine. She completed a combined internal medicine-pediatrics residency at Yale University followed by an endocrinology fellowship at the University of South Carolina.

As of September 2025, Dr. Twining reported no ongoing external relationships.

Dr. Waheed is ABIM Board Certified in Internal Medicine and Nephrology, and an Associate Professor at the Emory University School of Medicine. Her clinical work is based out of Grady Memorial Hospital in Atlanta which caters to the underserved population in the area. Prior to that, she practiced at Piedmont Kidney Institute in Atlanta. She is the Chair of the ABIM Nephrology Board. 

Dr. Waheed has served as the Medical Director of the Home Dialysis Program at Wisconsin Dialysis Institute. In addition, she has been involved in improving the clinical care delivered to patients by serving on the medical review committee for the end-stage renal disease networks. She is actively involved in developing material and initiatives to decrease infection risks in dialysis units as the chair of the Quality, Assessment, Improvement and Education workgroup of the Nephrologists Transforming Dialysis Safety, which is a collaborative effort between the Centers for Disease Control and Prevention and the American Society of Nephrology (ASN). 

Dr. Waheed has also been actively involved in education, both locally and nationally. She was the Director of the Medical School Renal Pathophysiology course and Associate Fellowship Director at the University of Wisconsin. Through her involvement with ASN, she has been actively involved in shaping the future of the nephrology workforce as a part of the ASN Workforce and Training Committee. In addition, she developed questions for the nephrology in-training exams and kidney self-assessment program. 

Her research interests include kidney disease in HIV patients, peritoneal dialysis and issues involving nephrology education for trainees. 

Dr. Waheed received her medical degree from the Aga Khan University in Pakistan and then completed her internal medicine residency at University of Cincinnati and fellowship at the Johns Hopkins Hospital. 

As of March 2026, Dr. Waheed reported the following external relationships:  

Dr. Waheed serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• The American Society of Nephrology, chair, Quality Assessment, Improvement and Education Steering Committee, receiving a stipend.

Dr. Wardrop is a career clinician and educator and the Chief Medical Officer at Northeast Ohio Medical University (NEOMED) Healthcare where he is also a Professor of Medicine and Pediatrics. Previously, Dr. Wardrop was Program Director of the Internal Medicine Residency and Vice Chair of Academic Medicine at Cleveland Clinic. He also led the top-rated Combined Med-Peds Residency at the University of North Carolina, was founding faculty at the Virginia Tech Carilion School of Medicine and founding Associate Dean for Biomedical Affairs at Campbell University School of Osteopathic Medicine. 

Throughout his career, he has practiced both as an internal medicine specialist and pediatrician and was recognized by the American College of Physicians (ACP) as one of America's top 10 hospitalists in 2018. He is ABIM Board Certified in Internal Medicine and board certified by the American Board of Pediatrics in Pediatrics. 

Dr. Wardrop is the Chair of the ABIM Internal Medicine Board and serves on the ABIM Council and the ABIM Board of Directors Conflict of Interest subcommittee. In 2026, he joined the ABIM Foundation Board of Trustees. 

Dr. Wardrop has held several national leadership positions within ACP, the Alliance for Academic Internal Medicine (AAIM) and the American Academy of Pediatrics (AAP). He has served as Chair of the Council of Early Career Physicians and as a member of the ACP Board of Regents. Within AAIM, he has served on the AAIM Education Committee and the AAIM Graduate Medical Education Funding Task Force and chaired the AAIM Faculty Development Committee. Within AAP, Dr. Wardrop was a member of the Section of Medicine and Pediatrics Executive Council from 2015 to 2018. 

Dr. Wardrop attended Virginia Polytechnic Institute and State University, graduating in 1994 summa cum laude, with honors, in biology before graduating from the Ohio State University with a doctoral degree in molecular virology and immunology in 2000 and his medical degree cum laude in 2002. He completed combined internal medicine and pediatrics residency and served as Chief Resident in Internal Medicine at the University of North Carolina at Chapel Hill. 

As of September 2025, Dr. Wardrop reported no ongoing external relationships.